Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Am J Ophthalmol. 2021 May 11;228:152–158. doi: 10.1016/j.ajo.2021.03.043

Table 2.

Classification Criteria for Multifocal Choroiditis with Panuveitis

Criteria
1. Multifocal choroiditis with
 a. Oval or round lesions AND
 b. Predominant lesion size >125 μm
AND
2. Characteristic appearance
 a. “Punched-out atrophic” chorioretinal scars OR
 b. Active lesions with more than minimal vitreous inflammation
AND
3. Inflammatory lesions and/or characteristic scars involving the mid-periphery or periphery with or without posterior pole involvement
Exclusions
1. Positive serologic test for syphilis using a treponemal test
2. Evidence of sarcoidosis (either bilateral hilar adenopathy on chest imaging or tissue biopsy demonstrating non-caseating granulomata)
3. In tuberculosis-endemic regions or tuberculosis-exposed individuals*, evidence of infection with Mycobacterium tuberculosis
 a. Histologically- or microbiologically-confirmed infection with M. tuberculosis OR
 b. Positive interferon-Ɣ release assay (IGRA) OR
 c. Positive tuberculin skin test§
*

Testing not needed in tuberculosis non-endemic regions.

E.g. biopsy, fluorochrome stain, culture, or polymerase chain reaction based assay.

E.g. Quantiferon-gold or T-spot.

§

E.g. purified protein derivative; a positive result should be >10 mm induration